nipocalimabgeneralized myasthenia gravis
…o], ocular [3.5/nipocalimab; 2.8/placebo], and respiratory [1.1/nipocalimab; 1.0/placebo]. Mean CFB favored nipocalimab (p<0.05), with resp…
4articles mentioning drugs
22drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Nipocalimab ×
Nipocalimab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Nipocalimab
4 articles · page 1 of 1Nipocalimabgeneralized myasthenia gravisgMG
…l-tolerated, with no serious adverse events reported.Conclusion Nipocalimab demonstrated both efficacy and safety in a 6-month trial involv…
nipocalimabgeneralized myasthenia gravisgMGNCT04951622
…Objective To evaluate the long-term safety and efficacy of nipocalimab, an FcRn blocker, in patients with generalized myasthenia gravi…
certolizumabnipocalimabDisease Activity Score 28rheumatoid arthritisRAcombination therapy
…e in the primary endpoint and secondary endpoints compared with certolizumab monotherapy in participants with active RA.…